platoseedplatoseed
Agents for Accelerated Clinical Trial Design
Delineate is building AI agents to design better clinical trials faster. This is a $10B dollar market, where saving even 1 day along the process is equal to $1-5M in revenue potential. We process existing clinical trial research into specialized datasets saving scientists months of effort. Delineate is working with two of the largest pharmaceutical companies. With one of our customers, we are helping them get to the next phase of trials faster by creating the largest dataset on a drug class ever constructed.
Delineate builds models from the totality of available evidence to support accelerated, quantitatively-grounded decisions across therapeutic areas for development, regulatory, and commercial teams.
Delineate creates quantitative models by integrating all available evidence to enable faster, data-driven decision making in clinical trial design and related processes. The approach focuses on providing quantitative evidence for consequential decisions in development, regulatory, and commercial contexts.
Who it’s for: Pharmaceutical and biotech companies, including development, regulatory, and commercial teams seeking accelerated, evidence-based decision making in clinical trial design and related areas.
Co-founder at Delineate. Previously she was an MIT PhD Candidate in Biological Engineering and worked at Pfizer and AstraZeneca where she focused on applying AI to modeling and simulation for drug development optimization.
Co-Founder and CTO of Delineate. Masters thesis in Robotics/AI with 2 research publications. Former technical project manager for high impact digital transformation projects within Skunkworks (Advanced Development) division at Lockheed Martin.
Extract meaningful data from biopharma research and patents at scale
Delineate provides data extraction and analysis of biopharma research papers and patents at scale, including figures and plots, using custom LLM and computer-vision models with QC. They partner with top-10 pharma companies to perform large meta-analyses, increasing processed studies 15x and reducing study time from months to weeks.
The world's first AI-maximalist pharma company
Agents that accelerate clinical trials.
